Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Sensitive

Type 2 diabetes

OPRM1 · rs3778156

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−8, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 50,251 African American cases, 103,909 African American controls, 88,109 East Asian ancestry cases, 339,395 East Asian ancestry controls, 242,283 European ancestry cases, 1,569,734 European ancestry controls, 29,375 Hispanic cases, 59,368 Hispanic controls, 1,602 South African ancestry cases, 976 South African ancestry controls, 16,832 South Asian ancestry cases, 33,767 South Asian ancestry controls.

The effect The reported allele is G; the catalogue records no effect size ; p = 2 × 10−8.

How common The G allele had a frequency of about 14% in the people studied.

Where it sits Chromosome 6, band 6q25.2 — in an intron of OPRM1.

How common each version is

AG
Korean KRGDB
A 95.2% · G 4.8%
Korean Korea4K
A 95.1% · G 4.9%
Japanese ToMMo
A 96.5% · G 3.5%
Vietnamese
A 95.8% · G 4.2%
World gnomAD
A 83.9% · G 16.1%
World 1000 Genomes
A 88.9% · G 11.1%
World TOPMed
A 84.1% · G 15.9%

By ancestry gnomAD

East Asian
A 95.5% · G 4.5%
European (non-Finnish)
A 82.8% · G 17.2%
African / African American
A 81.7% · G 18.3%
South Asian
A 94.6% · G 5.4%
Admixed American (Latino)
A 87.5% · G 12.4%
Middle Eastern
A 90.1% · G 9.9%
Finnish
A 82.4% · G 17.6%
Ashkenazi Jewish
A 87.4% · G 12.6%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A No copy of the version the research linked to Type 2 diabetes. This is the starting point the study compared everyone against.
A/G One copy of the version the research linked to Type 2 diabetes. That is a smaller link than two copies.
G/G Two copies of the version the research linked to Type 2 diabetes. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Type 2 diabetes (rs3778156). MyGeneLog™. https://www.mygenelog.com/variants/rs3778156

← See all variants